GTN: MTX With, Without Dactinomycin May Be Effective Option
Patients in the single-course MTX+ACTD arm had a 46.81% CR rate after initial therapy.
Society of Gynecologic Oncology (SGO)
Gynecologic Abdominal Surgery: Liposomal Bupivacaine May Reduce Opioid Use
Researchers randomly assigned 120 patients to receive bupivacaine HCl or liposomal bupivacaine.
Indocyanine Green Improves Sentinel Node Detection in Uterine Malignancies
Overall, 257 vs 527 SLNs were detected by isosulfan blue vs ICG, respectively.
Opioid Prescription Protocol Decreases Opioid Use After Gynecologic Surgery
There were no reported changes in pain scores after surgery.
Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma
Researchers randomly assigned 74 patients to receive everolimus plus letrozole daily or tamoxifen daily plus medroxyprogesterone daily on alternating weeks.
Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers
The impact of the ACA on health insurance access among women diagnosed with a gynecologic cancer was previously unestablished.
Hypermethylation of DNA Repair Genes in Ovarian Carcinoma
Hypermethylation of HRR-associated genes was not associated with improved survival in ovarian cancer.
Sentinel Lymph Node Mapping Cost-effective in Endometrial Carcinoma
Study data suggest that SLN mapping is more cost-effective and more efficacious than routine LND or selective LND.
Elderly Patients and Treatment Tolerance in Phase 1 Trials
Study results suggest that carefully selected elderly patients with recurrent or refractory gynecologic malignancy should be enrolled in phase 1 trials.
Patients With Ovarian Cancer Rank Nausea as Most Concerning Chemotherapy Side Effect
Patients with newly diagnosed ovarian cancer rank nausea as the most concerning side effect associated with chemotherapy.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in SGO 2017
Loading... 
Loading...